LINCOLN NATIONAL CORP - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$218,645
+1.5%
5,794
+22.6%
0.00%0.0%
Q2 2023$215,338
+2.3%
4,727
-8.9%
0.00%0.0%
Q1 2023$210,446
-39.6%
5,189
-24.1%
0.00%
-50.0%
Q4 2022$348,323
+15.0%
6,833
+21.5%
0.01%
+14.3%
Q3 2022$303,000
-18.3%
5,623
-2.6%
0.01%
-22.2%
Q2 2022$371,000
-35.3%
5,773
-21.8%
0.01%
-25.0%
Q1 2022$573,000
-13.1%
7,386
-3.8%
0.01%
-7.7%
Q4 2021$659,000
+23.2%
7,675
+15.4%
0.01%
+8.3%
Q3 2021$535,000
-2.0%
6,651
-1.9%
0.01%0.0%
Q2 2021$546,000
-16.4%
6,778
-12.5%
0.01%
-25.0%
Q1 2021$653,000
-12.8%
7,743
-17.0%
0.02%
-20.0%
Q4 2020$749,000
+19.3%
9,332
+19.4%
0.02%
+5.3%
Q3 2020$628,000
-7.0%
7,813
-0.3%
0.02%
-13.6%
Q2 2020$675,000
+9.8%
7,839
+3.4%
0.02%
-4.3%
Q1 2020$615,000
+1.3%
7,582
+4.4%
0.02%
+15.0%
Q4 2019$607,000
+53.3%
7,259
+60.3%
0.02%
+33.3%
Q3 2019$396,000
+11.5%
4,529
+4.6%
0.02%
+7.1%
Q2 2019$355,000
-1.7%
4,331
-2.2%
0.01%
-6.7%
Q1 2019$361,000
+21.1%
4,429
-2.3%
0.02%
+7.1%
Q4 2018$298,000
-20.1%
4,534
-6.3%
0.01%
+7.7%
Q3 2018$373,000
+0.3%
4,840
-3.8%
0.01%
-7.1%
Q2 2018$372,000
+14.1%
5,033
+0.4%
0.01%
+16.7%
Q1 2018$326,000
-49.6%
5,013
-49.9%
0.01%
-40.0%
Q4 2017$647,000
+113.5%
10,012
+107.2%
0.02%
+53.8%
Q3 2017$303,000
+13.5%
4,833
+9.7%
0.01%0.0%
Q2 2017$267,000
+14.1%
4,404
-2.3%
0.01%
+8.3%
Q1 2017$234,0004,5090.01%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders